Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Bichet

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Kidney International|August 31, 2012
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremiaWilliam T Abraham, Johannes Hensen, Peter A Gross, et al.
NDT Plus|June 2, 2011
Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptorLene N Nejsum, Tomas M Christensen, Joris H Robben, et al.
Journal of the American Society of Nephrology : JASN|February 6, 2010
Targeted inactivation of EGF receptor inhibits renal collecting duct development and functionZhao Zhang, Elena Pascuet, Pierre-Alain Hueber, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Nature Reviews. Disease Primers|August 10, 2019
Diabetes insipidusMirjam Christ-Crain, Daniel G Bichet, Wiebke K Fenske, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2020
Correction: Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Clinical Kidney Journal|January 4, 2021
Erratum: Long-term outcome in inherited nephrogenic diabetes insipidusSonia Sharma, Emma Ashton, Daniela Iancu, et al.
Analytica Chimica Acta|March 14, 2018
Analysis of globotriaosylceramide (Gb<sub>3</sub>) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometryAmanda Toupin, Pamela Lavoie, Marie-Françoise Arthus, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 22, 2016
Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V<sub>1A</sub> receptorsChristopher Taveau, Catherine Chollet, Daniel G Bichet, et al.
Clinical Kidney Journal|April 13, 2019
Long-term outcome in inherited nephrogenic diabetes insipidusSonia Sharma, Emma Ashton, Daniela Iancu, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Kidney International|August 31, 2012
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremiaWilliam T Abraham, Johannes Hensen, Peter A Gross, et al.
NDT Plus|June 2, 2011
Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptorLene N Nejsum, Tomas M Christensen, Joris H Robben, et al.
Journal of the American Society of Nephrology : JASN|February 6, 2010
Targeted inactivation of EGF receptor inhibits renal collecting duct development and functionZhao Zhang, Elena Pascuet, Pierre-Alain Hueber, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Nature Reviews. Disease Primers|August 10, 2019
Diabetes insipidusMirjam Christ-Crain, Daniel G Bichet, Wiebke K Fenske, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2020
Correction: Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Clinical Kidney Journal|January 4, 2021
Erratum: Long-term outcome in inherited nephrogenic diabetes insipidusSonia Sharma, Emma Ashton, Daniela Iancu, et al.
Analytica Chimica Acta|March 14, 2018
Analysis of globotriaosylceramide (Gb<sub>3</sub>) isoforms/analogs in unfractionated leukocytes, B lymphocytes and monocytes from Fabry patients using ultra-high performance liquid chromatography/tandem mass spectrometryAmanda Toupin, Pamela Lavoie, Marie-Françoise Arthus, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 22, 2016
Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V<sub>1A</sub> receptorsChristopher Taveau, Catherine Chollet, Daniel G Bichet, et al.
Clinical Kidney Journal|April 13, 2019
Long-term outcome in inherited nephrogenic diabetes insipidusSonia Sharma, Emma Ashton, Daniela Iancu, et al.
Pageof 15